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and an annual knee X-ray, with 445 of them needing a knee brace during this period. 
During the study period there were 6,705 osteoarthritis-related hospitalizations, 
and over 10,000 combined physiotherapy(PT)/occupational therapy (OT) and home 
care nursing visits among patients prescribed HA. Hylan G-F 20 patients had fewer 
visits to a GP (36%) and specialist (39%), lower use of PT/OT (23% and 1%) and home 
care nursing (2%) services compared to other HA treatments (p< 0.05 for all com-
parisons). ConClusions: This analysis demonstrates that not all HA injections 
in patients with knee osteoarthritis represent similar resource utilization. Further 
real world examination of the effectiveness of HA for reducing clinical symptoms 
and improving health care resource utilization in knee osteoarthritis is warranted.
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objeCtives: The objective of this research report was to examine the relation-
ship between medication adherence levels and health care cost among patients 
with rheumatoid arthritis (RA). Methods: This study used a retrospective case 
comparison design to examine per member per month (PMPM) medical cost. The 
commercial population of patients with RA was extracted from two large claims 
data bases between years 2006 and 2009. The case cohort consisted of compliant 
patients (MPR ≥ 80%) receiving medication management from the Specialty divi-
sion of a large pharmacy retail chain. The comparison cohort consisted of non-
compliant patients (MPR < 80%) from a national benchmark pharmacy and medical 
claims data base. Using propensity scores, patients were matched on age, gender, 
risk score, socio-economic status, standard industrial classification code, comorbid 
conditions, and pre-medication gap. This process resulted in 512 one-to-one match 
pairs. Results: Patients with RA who were compliant to their medication regimen 
had 25% lower PMPM medical cost (in-patient, out-patient, professional, and emer-
gency room cost) than patients who were non-compliant ($637 vs. $855 respectively; 
P= 0.0458). The majority of this cost difference was due to in-patient cost which was 
46% lower for compliant patients, followed by professional cost which was 15% 
lower for compliant patients. A closer look at medical cost by levels of compliance 
reveals that PMPM medical cost decreased at each level of medication compliance 
described below. Patients with adherence levels less than 40% had PMPM cost of 
$1024, those with adherence levels between 40% and 80% had PMPM cost of $838, 
and patients with adherence levels greater than or equal to 80% had PMPM cost of 
$637. ConClusions: Medical cost decreases as adherence to the RA medication 
regimen increases. Given that the cost of treating RA can be extremely expensive, 
one approach to addressing this financial issue is to target medication adherence.
PMs48
withDrawn
PMs49
goliMuMaB utilization Patterns anD refill aDherence in Patients 
with rheuMatoiD arthritis, Psoriatic arthritis anD ankylosing 
sPonDylitis
Ellis L.1, Bolge S.1, Rice P.2
1Janssen Scientific Affairs, LLC, Horsham, PA, USA, 2Premier Research, Naperville, IL, USA
1Karolinska Institute, Solna, Sweden, 2OptumInsight, Stockholm, Sweden, 3Vilnius University, 
Faculty of Medicine, Vilnius, Lithuania, 4Bone Metabolism Unit, Istituto Auxologico Italiano 
IRCCS, Milan, Italy, 5Clinical Epidemiology Unit, Hospital Infantil Federico Gómez and Faculty 
of Medicine UNAM, Mexico city, Mexico, 6Fundación Jimenez Diaz, Madrid, Spain, 7Department 
of Internal Medicine, Division of Endocrinology and Metabolism, Medical University of Graz, 
Graz, Austria, 8Ural State Medical Academy, Yekaterinburg, Russia, 9Academic Unit of Bone 
Metabolism, Metabolic Bone Centre, University of Sheffield, Sheffield, UK, 10Department of 
Medicine, NorthWest Academic Centre, The University of Melbourne, Melbourne, Australia, 
11INSERM U1059, CHU-St-Etienne, Saint Etienne, France, 12LIME/MMC, Karolinska Institutet, 
Stockholm, Sweden, 13WHO Collaborating Centre for Metabolic Bone Diseases, University of 
Sheffield, Sheffield, UK
objeCtives: The International Costs and Utilities Related to Osteoporotic fractures 
Study (ICUROS) is an ongoing 18 months prospective observational study with the 
objective of estimating resource use and health related quality of life related to osteo-
porotic fractures. This study aims to describe the resource utilization after vertebral 
fractures (sustained during 2007-2012) pooled from nine countries: Australia, Austria, 
France, Italy, Lithuania, Mexico, Russia, Spain, and the UK. Methods: Patients stud-
ied were ≥ 50 years and lived at home prior to fracture. Data were collected through 
patient interviews and review of medical records: at baseline, 4, 12, and 18 months after 
fracture. Only resource use related to the fracture event was collected. Results: There 
were 636, 572, and 536 patients available for analysis at 4, 12 and 18 months follow-up, 
respectively. The mean age (±SD) at fracture was 70±10 years and 81% were women. 
45% of patients were hospitalized. Mean hospital length of stay (LoS) (±SD) was 5.7±12.4 
days during months 0-4 and 0.9±9.8 during months 5-18. The mean number of physi-
cian visits (±SD) was 2.8±2.7 during months 0-4 and 1.9±3.4 between months 5-18. The 
mean number of nurse visits (±SD) was 1.4±8.5 and 1.5±19.9 during the corresponding 
periods, respectively. During months 0-4, 72% of patients used analgesics, 59% calcium/
vitamin D, and 41% pharmacological interventions for osteoporosis. The respective 
uptakes for months 5-18 were 56%, 55% and 34%. ConClusions: The majority of 
health care consumption related to vertebral fracture occurs during the first 4 months 
but substantial consumption persists up to 18 months after fracture.
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objeCtives: Musculoskeletal conditions are the primary cause of physical disability 
in the United States, and have implications for workplace productivity and employer 
health costs. This study determined the influence of employer-sponsored, onsite 
chiropractic care on health care utilization. Methods: A retrospective claims anal-
ysis of members of an employer-sponsored health plan receiving chiropractic care 
exclusively onsite or offsite from 2010-2012. Data were obtained from the employ-
er’s health benefits administration program. Eligible participants had continuous 
enrollment in the health plan and ≥ 1 billing code for chiropractic services during 
the 36-month study period. Utilization was assessed in 2 categories: radiological 
procedures and clinical care. Utilization differences were evaluated by having ≥ 1 
health care event in any category. Continuous variables were summarized as means, 
and binary variables as counts and proportions. Differences were assessed via chi-
square test for categorical variables and t-test and Kruskal-Wallis non-parametric 
test for continuous variables. Comparisons were considered significant at alpha = 
0.05. Results: The analysis included 876 onsite and 759 offsite participants. The 
populations were similar in gender; the onsite group was slightly younger. The 
offsite group received more radiology services overall (55.5% vs 38.2%, P< 0.001) 
including x-ray (46.0% vs 26.6%; P < 0.0001); ultrasound (15.8% vs 10.7%, P< 0.0001), 
and magnetic resonance imaging (14.6% vs 12.4%, P< 0.0001); had higher outpatient 
(47.3% vs 30.2%, P< 0.0001) and emergency department (19.0% vs 13.1%; P = 0.022) uti-
lization; and demonstrated greater use of chiropractic care (mean 15.2 vs 9.16 visits; 
P< 0.0001) and physical therapy (mean 9.6 vs 1.5 visits; P< 0.0001). ConClusions: 
In patients needing chiropractic care, those utilizing onsite services had lower 
health care utilization, including radiology services , clinical care, and counts of 
chiropractic and physical therapy services. The study results support the value of 
chiropractic services offered at onsite health centers, where more tightly managed 
and evidence-based approaches to musculoskeletal conditions can be facilitated.
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objeCtives: To examine the health care resource utilization in patients with knee 
osteoarthritis and treated with Hylan G-F 20 (Synvisc, Genzyme Biosurgery) com-
pared with patients treated with alternative intra-articular hyaluronic acid (HA) 
injections in Ontario, Canada. Methods: This is an observational, prospective 
cohort of patients 18 years and older who, between June 1, 1999 and December 31, 
2012 had: 1) a diagnosis of knee osteoarthritis identified by ICD 9-10 or text coding; 2) 
received at least 1 treatment cycle with intra-articular HA and; 3) complete pain and 
mobility data for each treatment cycle. Data from the Southwestern Ontario (SWO) 
database, has been continuously compiled since 1999 and includes demographic, 
biometric, laboratory, diagnostic and health resource measures as collected in a 
primary care setting. Health care resource utilization included clinic visits, emer-
gency visits, hospitalizations, home care visits, knee bracing, radiographs, and work 
absenteeism. Differences between treatments were compared using independent 
sample t-tests. Results: 6,618 patients met all inclusion criteria of which 44% 
were treated with Hylan G-F 20. Patients were similar across treatment groups. 
During the follow-up period, patients received, on average, 6 HA treatment cycles 
